Clinical Project Manager
Rose was the Programme Manager for the Scalable behavioural weight management programmes for the prevention and treatment of type 2 diabetes led by Dr Amy Ahern and Professor Simon Griffin. She joined the Unit in 2016 to work on various projects, including the publication of the GLINT feasibility trial Glucose Lowering in non-diabetic hyperglycaemia Trial (GLINT) and supporting work on the application for the Unit to become a UKCRC registered Clinical Trials Unit, now registered as the Cambridge Epidemiology & Trials Unit (CETU, CTU064) Cambridge Epidemiology and Trials Unit
Rose has thirteen years of clinical research experience. She has worked in different research settings: the hospital (NHS and abroad), the pharmaceutical industry and the University of Cambridge. She has an MSc in Biology and started her career in obesity research. After she moved to the UK in 2006, Rose became a clinical trials monitor at PPD Global Ltd on Granta Park. After several years of monitoring commercial clinical trials, she came to the Biomedical Campus to work in the CUH Research Governance team and from there she moved into research project management.
Rose co-organises the Research Project Managers group on the Biomedical Campus (with Mrs Marie-Christine Laurent, MRC-MBU) and is a member of the Campus’s Bicycle User Group – Walking Action Group (BUG-WAG).
Research interests: active lifestyle, weight management, prevention
Project management qualification: PRINCE2
Griffin SJ, Bethel MA, Holman RR, Khunti K, Wareham N, Brierley G, et al (including Eichenberger RI). Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT. Health Technol Assess 2018;22(18).
Fasting and meal-suppressed ghrelin levels before and after intragastric balloons and balloon-induced weight loss, Mathus-Vliegen, EM, Eichenberger RI. Obes Surg. 2014 Jan;24(1):85-94. doi:10.1007/s11695-013-1053-5